Inhibition of cancer growth in vitro and in vivo by a novel ROS-modulating agent with ability to eliminate stem-like cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibition of cancer growth in vitro and in vivo by a novel ROS-modulating agent with ability to eliminate stem-like cancer cells

Published:2017-06 Issue:6 Volume:8 Page:e2887-e2887
ISSN:2041-4889
Container-title:Cell Death & Disease
language:en
Short-container-title:Cell Death Dis

Author:

Wang Jiankang,Luo Bingling,Li Xiaobing,Lu Wenhua,Yang Jing,Hu Yumin,Huang Peng,Wen Shijun

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology

Link

http://www.nature.com/articles/cddis2017272.pdf

Reference34 articles.

1. Schumacker PT . Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell 2006; 10: 175–176.

2. D'Autreaux B, Toledano MB . ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 2007; 8: 813–824.

3. Lin MT, Beal MF . Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006; 443: 787–795.

4. Ott M, Gogvadze V, Orrenius S, Zhivotovsky B . Mitochondria, oxidative stress and cell death. Apoptosis 2007; 12: 913–922.

5. Trachootham D, Alexandre J, Huang P . Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 2009; 8: 579–591.

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glycolysis, the sweet appetite of the tumor microenvironment;Cancer Letters;2024-09

2. Targeting ROS in cancer: rationale and strategies;Nature Reviews Drug Discovery;2024-07-09

3. Antiproliferative activity of platinum(II) and copper(II) complexes containing novel biquinoxaline ligands;Metallomics;2024-01-05

4. Predominant factors influencing reactive oxygen species in cancer stem cells;Journal of Cellular Biochemistry;2023-11-24

5. Nanoparticle (NP)-mediated APOC1 silencing to inhibit MAPK/ERK and NF-κB pathway and suppress breast cancer growth and metastasis;Science China Life Sciences;2023-08-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3